ABSTRACT

Lung cancer is one of the most common cancers in the world. Cigarette smoking is the cause of most lung cancers, but there are other factors. There are two main types of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer. NSCLC accounts for about 80% of lung cancers, and adenocarcinoma is the most common type. Bronchioloalveolar carcinoma is a rare subtype of lung adenocarcinoma. Below we report the case of a patient with bronchioloalveolar carcinoma.

KEYWORDS

Bronchioloalveolar carcinoma, pseudocavitation, lepidic growth pattern.

REFERENCES

1. http://www.cancer.org/downloads/STT/2008 CAFFfinalsecured.pdf

2. http://www.inegi.org.mx/est/contenidos/espanol/proyectos/continuas/vitales/BD/tabulados/ConsultaMortalidad.asp

3. http://www.inegi.org.mx/inegi/contenidos/espanol/prensa/Contenidos/estadisticas/2007/cancer07.pdf

4. Medina F, Barrera R, Morales J, Echegoyen R, Chavarria J, Rébora F. Primary lung cancer in Mexico city: a report of 1,019 cases. Lung Cancer 1996; 14: 185-93.

5. Medina-Morales F, Salazar-Flores M. Frecuencia y patrón cambiante del cáncer pulmonar en México. Salud Pública Mex 2000; 42: 333-36.

6. Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 2004; 45(2): 137-42.

7. Alberg AJ, Samet JM. Epidemiology of Lung Cancer. Chest 2003; 123: 21S-49S.

8. Raz DJ, He B, Rosell R, Jablons DM. Bronchioloalveolar carcinoma: a review. Clin Lung Cancer 2006; 7(5): 313-22.

9. Delgado J, Martinez LM, Sanchez TT, Ramirez A, Iturria C, Gonzalez-Avila G. Lung cancer pathogenesis associated with wood smoke exposure. Chest. 2005; 128: 124-31.

10. Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. RadioGraphics 1997; 17: 1345-57.

11. Henschke CI, McCauley DI, Yanke-levitz DI, Naidich DF, McGuiness DP, Miettinen G, et al. When early-stage lung cancer is detected and surgery is possible, 5-year survival rates can reach 85%. («Early Lung Cancer Action Project: overall design and findings from baseline screening»). Lancet 1999; 354: 99-105.

12. Clayton F. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer 1986; 57: 1555-64.

13. Rusch VW, Appelman HD, Byhardt R, et al. Lung. In: FL Greene, DL Page, ID Fleming, et al., eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag, 2002: 167-181.

14. Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, Morere JF, Souquet PJ, Soria JC, Morin, Milleron B. IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype. J Thorac Oncol 2009; 4: 1126-35.

15. West H, Harpole D, Travis W. Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer. Chest 2009; 136: 1112-8.

16. Puerto VL. Overview of advanced non-small-cell lung cancer treatment in Mexico. BMC Proc 2008; 2 Suppl 2: S2.